Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Magnesium SulfateThromboelastometry
Interventions
DRUG

Magnesium sulphate

"In patients allocated to the MS group, a fixed dose of magnesium sulfate diluted in a fixed volume of natural saline will be administered intravenously.~Thromboelastometry will be performed pre and post magnesium administration."

OTHER

Placebo Drug

"In patients allocated to the NS group, a fixed dose of natural saline will be administered intravenously, through a fixed volume of solution.~Thromboelastometry will be performed pre and post magnesium administration."

Trial Locations (1)

11528

RECRUITING

Aretaieion University Hospital, Athens

All Listed Sponsors
collaborator

Aretaieion University Hospital

OTHER

lead

Marianna Mavromati

OTHER